Meeting Abstracts
V. Perkovic, S.C. Bain, G. Bakris, J.B. Buse, T. Gondolf, T. Idorn, N. Lausvig, K. Mahaffey, S.P. Marso, M.A. Nauck, R. Pratley, P. Rossing, B. Zinman, J. Mann. Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER. 55th EASD Annual Meeting, 2019.
S. Verma, S.C. Bain, D.L. Bhatt, L.A. Leiter, C.D. Mazer, D.K. McGuire, R. Pratley, B. Zinman, S. Lindberg, S. Rasmussen, H. Vrazic, J.B. Buse. Liraglutide and semaglutide improve cardiovascular and renal outcomes across most BMI categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials. 55th EASD Annual Meeting, 2019.
V. Hamidi, K. Riggs, L. Zhu, K. Bermudez Saint Andre, C. Westby, S. Coverdale, A. Dursteler, H. Wang, H. Taegtmeyer, A.D. Gutierrez. The role of acute incretin therapy on endothelium-dependent and endothelium-independent postprandial vasodilation in humans with prediabetes. 55th EASD Annual Meeting, 2019.
O. McCarthy, O. Moser, M.L. Eckstein, S.N. Scott, M. Riddell, M. Fisher, F.Y. Fontana, K. Skroce, L. Festa, P.H. Lagrou, P. Southerland, C.A. Hayes, M.P. Christiansen, B.W. Bode, C. Stettler, R.M. Bracken. Time Spent in Glycaemic Ranges and Carbohydrate Intake during Cycling in Professional Cyclists with Type 1 Diabetes. American Diabetes Association 79th Scientific Sessions, 2019.
M.L. Eckstein, O. Moser, A. Mueller, P. Birnbaumer, F. Aberer, G. Koehler, C. Sourij, H. Kojzar, P.N. Pferschy, P. Dietz, R.M. Bracken, P. Hofmann, H. Sourij. Oral Carbohydrate Demand during Endurance Exercise Is Dependent on Pre-exercise Blood Glucose Concentration in People with Type 1 Diabetes: A Randomized Crossover Trial. American Diabetes Association 79th Scientific Sessions, 2019.
O. Moser, M.P. Christiansen, B.W. Bode, C. Stettler, S.N. Scott, M. Fisher, C.A. Hayes, R.M. Bracken, M.L. Eckstein, O. Mccarthy, M. Riddell, F.Y. Fontana, K. Skroce, L. Festa, P.H. Lagrou, P. Southerland. Greater Time Spent in Hypoglycemia during Night Compared with Day during Intensified Training in Professional Cyclists with Type 1 Diabetes—A Prospective Observational Study. American Diabetes Association 79th Scientific Sessions, 2019.
O. Moser, M.L. Eckstein, O. McCarthy, R. Deere, J. Pitt, D.M. Williams, J. Hayes, S.C. Bain, R.M. Bracken. Diminished Sensor Performance of the Abbott Freestyle Libre Intermittently-Viewed Continuous Glucose Monitoring System (ICGMS) during Hypoglycemia and Acute Exercise in People with Type 1 Diabetes. American Diabetes Association 79th Scientific Sessions, 2019.
M.L. Eckstein, M. Fisher, C.A. Hayes, P. Southerland, C. Stettler, P.H. Lagrou, B.W. Bode, R.M. Bracken, O. Moser, O. Mccarthy, S.N. Scott, M. Riddell, F.Y. Fontana, K. Skroce, M.P. Christiansen, L. Festa. Sweet Performance: Associations of Maximum Physiological Performance and Diabetes in a Group of World Class Road Cyclists with Type 1 Diabetes. American Diabetes Association 79th Scientific Sessions, 2019.
K. Thong, J. Chung-Wah-Cheong, M. Yadagiri, M.L. Cull, A. Bickerton, S.M. Phillips, A. Evans, D.K. Sennik, A. Rohilla, H. Reid, D.S. Morris, M. Atkin, A.M. Robinson, D.M. Williams, J.W. Stephens, I.W. Gallen, K. Adamson, R.E.J. Ryder. Predictors of Glycaemic and Weight Response to Empagliflozin Treatment: The ABCD Nationwide Empagliflozin Audit. American Diabetes Association 79th Scientific Sessions, 2019.
K. Thong, J. Chung-Wah-Cheong, M. Yadagiri, M.L. Cull, A. Bickerton, S.M. Phillips, A. Evans, D.K. Sennik, A. Rohilla, H. Reid, D.S. Morris, M. Atkin, A.M. Robinson, D.M. Williams, J.W. Stephens, K. Adamson, I.W. Gallen, R.E.J. Ryder. Characteristics and Treatment Outcomes of Patients Treated with Empagliflozin in the ABCD Nationwide Empagliflozin Audit. American Diabetes Association 79th Scientific Sessions, 2019.